Nuclear PI-PLC&bgr;1 and Myelodysplastic Syndromes: Genetics and Epigenetics

E-ISSN： 1873-4286|18|13|1751-1754

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.13, 2012-05, pp. : 1751-1754

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 9, 2008-10 ,pp. : 902-902

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 11, 2014-10 ,pp. : 873-883

Bentham Science Publishers

Access to resources Recommend Favorite

Decitabine: In Myelodysplastic Syndromes

By McKeage Kate Croom Katherine F.

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 951-958

Adis International

Access to resources Recommend Favorite

Azacitidine: In Myelodysplastic Syndromes

By Siddiqui M. Asif A. Scott Lesley J.

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1781-1789

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of myelodysplastic syndromes

By Galili Naomi Raza Azra

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1889-1899

Informa Healthcare

Access to resources Recommend Favorite